companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

LINQUAN COUNTY EDIBLE OIL FTY

-China

Company Name:
Corporate Name:
LINQUAN COUNTY EDIBLE OIL FTY
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 8 Renmin Road, Linquan County, Anhui,,,China 
ZIP Code:
Postal Code:
236400 
Telephone Number: 86-558-6512181 
Fax Number:  
Website:
 
Email:
 
Industrial Classification: Agriculture -- Plant oils 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
FEIXI COUNTY SIHEXIANG GRAIN & EDIBLE OIL FTY
HEILONGJIANG PROVINCE XUNKE FARM INDUSTRY CENTER GRAIN & EDIBLE OIL FTY
HUADIAN CITY BEITAIZIXIANG OIL FTY
Next company profile:
ZHENGAN XIAOZHUANG BUILDING MATERIALS CHANG
HUIMINXIAN WEIJIZHEN GRAIN & EDIBLE OIL FTY
XILIN COUNTY GINGER CHINA WOOD OIL CO LTD










Company News:
  • Tesofensine - an overview | ScienceDirect Topics
    Tesofensine Tesofensine is a dopamine, serotonin, and noradrenaline (triple) reuptake inhibitor originally developed by NeuroSearch for the treatment of Alzheimer's disease and Parkinson's disease Development of the compound for these neurological indications was unsuccessful but significant weight loss was reported during the clinical trials in Parkinson's disease 166 Hence, tesofensine is
  • Tesofensine - an overview | ScienceDirect Topics
    Tesofensine (with metoprolol) Tesofensine is a presynaptic uptake inhibitor of noradrenaline, dopamine and serotonin A phase II, randomised, double-blind, placebo-controlled trial included 203 obese patients (body-mass index 30–≤40 kg m2) who were prescribed an energy restricted diet together with either tesofensine 0 25 to 1 0 mg or placebo, once daily for 24 weeks [30] The two highest
  • Tesofensine - an overview | ScienceDirect Topics
    Tesofensine Tesofensine is an inhibitor of neuronal reuptake of dopamine, noradrenaline, and serotonin There has been considerable interest in this investigational drug for weight reduction as an adjunct to energy restriction Placebo-controlled studies In a phase II clinical trial of tesofensine in Denmark there was a significant reduction in body weight compared with placebo [118C] The
  • Tesofensine - an overview | ScienceDirect Topics
    Tesofensine is a compound originally developed for the treatment of neurological diseases such as Alzheimer's and Parkinson's However, it was found to cause significant weight loss during clinical trials in Parkinson's disease, leading to its current development for the treatment of obesity and type 2 diabetes AI generated definition based on: Animal and Translational Models for CNS Drug
  • Effect of tesofensine on bodyweight loss, body . . . - ScienceDirect
    Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
  • Tesofensine - Weight Loss - AnabolicMinds. com
    Tesofensine has in previous studies provided a clinical significant and convincing weight loss in obese patients Therefore, this study may lead to market approval of a novel and highly effective treatment in Mexico, where overweight and obesity represents a severe health problem," says Jørgen Drejer, CEO of Saniona
  • Tesofensine, a novel triple monoamine re-uptake inhibitor with anti . . .
    Abstract Tesofensine (TE) is a novel triple monoamine re-uptake inhibitor inducing a potent inhibition of the re-uptake process in the synaptic cleft of the neurotransmitters dopamine, norepinephrine, and serotonin
  • Triple monoamine inhibitor tesofensine decreases food intake, body . . .
    The novel triple monoamine inhibitor tesofensine blocks dopamine, serotonin and norepinephrine re-uptake and is a promising candidate for the treatmen…




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer